Envestnet Asset Management Inc Durect Corp Transaction History

Envestnet Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.43 - $5.9 $137 - $1,882	319 Added 2.04%	15,982 $9,000
Q1 2022 May 04, 2022	SELL	$0.55 - $0.98 $1,462 - $2,605	-2,659 Reduced 14.51%	15,663 $10,000
Q4 2021 Feb 04, 2022	BUY	$0.9 - $1.31 $339 - $493	377 Added 2.1%	18,322 $18,000
Q3 2021 Oct 07, 2021	BUY	$1.21 - $1.61 $2,401 - $3,195	1,985 Added 12.44%	17,945 $23,000
Q2 2021 Aug 04, 2021	BUY	$1.6 - $2.02 $3,358 - $4,239	2,099 Added 15.14%	15,960 $26,000
Q1 2021 May 04, 2021	BUY	$1.86 - $2.87 $2,814 - $4,342	1,513 Added 12.25%	13,861 $27,000
Q4 2020 Feb 02, 2021	BUY	$1.65 - $2.43 $539 - $794	327 Added 2.72%	12,348 $26,000
Q3 2020 Oct 09, 2020	BUY	$1.6 - $2.35 $176 - $258	110 Added 0.92%	12,021 $21,000
Q2 2020 Jul 08, 2020	BUY	$1.33 - $2.76 $15,841 - $32,874	11,911 New	11,911 $28,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $189M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.